| __timestamp | Evotec SE | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 60118000 | 179279000 |
| Thursday, January 1, 2015 | 89690000 | 186359000 |
| Friday, January 1, 2016 | 105953000 | 171785000 |
| Sunday, January 1, 2017 | 175062000 | 208136000 |
| Monday, January 1, 2018 | 263389000 | 198405000 |
| Tuesday, January 1, 2019 | 313546000 | 224169000 |
| Wednesday, January 1, 2020 | 375181000 | 245044000 |
| Friday, January 1, 2021 | 466491000 | 252314000 |
| Saturday, January 1, 2022 | 577383000 | 268225000 |
| Sunday, January 1, 2023 | 606375000 | 304629000 |
| Monday, January 1, 2024 | 324203000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Taro Pharmaceutical Industries Ltd. and Evotec SE, two prominent players, have shown distinct trends in their cost of revenue from 2014 to 2023. Taro's cost of revenue has seen a steady increase, rising approximately 70% over the decade, peaking at 324 million in 2024. Meanwhile, Evotec SE has experienced a more dramatic surge, with costs escalating by over 900%, reaching 606 million in 2023. This stark contrast highlights Evotec's aggressive expansion strategy compared to Taro's more measured growth. The data for 2024 is missing for Evotec, leaving room for speculation on whether this trend will continue. As the pharmaceutical landscape shifts, these insights provide a window into the financial strategies of these industry giants.
Cost of Revenue: Key Insights for Johnson & Johnson and Evotec SE
Analyzing Cost of Revenue: Novartis AG and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Pfizer Inc. and Evotec SE
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Insmed Incorporated and Evotec SE
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses
Analyzing Cost of Revenue: Pharming Group N.V. and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Evotec SE
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Comparing Revenue Performance: Taro Pharmaceutical Industries Ltd. or Evotec SE?
Cost of Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.